Biotech stocks fell sharply Tuesday, with the Medical-Development group down 3.3%. Vaxcyte dropped 9.7%, Moderna lost 7.8%, Revolution Medicines fell 3.8%. The sell-off extends a two-month downtrend.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
